Pfizer bags rull FDA nod for BRAFTOVI combination in aggressive colorectal cancer
BRAFTOVI in combination with cetuximab and mFOLFOX6 had previously received accelerated approval in December 2024 based on objective response rate (ORR) results
BRAFTOVI in combination with cetuximab and mFOLFOX6 had previously received accelerated approval in December 2024 based on objective response rate (ORR) results
The new patents cover critical advancements in cochlear implant technology
The collaboration merges biomodal’s 5-base and 6-base sequencing solutions, duet +modC and duet evoC
The agreement ensures BIOEMTECH customers can consistently obtain Ac-225 for preclinical studies
40+ most innovative startups with disruptive contributions across MedTech, Medical Devices, BioPharma, Cell and Gene Therapy, AI and ML, Nutraceuticals, and Biomarkers exhibited their cutting-edge solutions
The acquisition marks the company’s strategic entry into the fast-growing Hormone Replacement Therapy (HRT) segment and significantly strengthens its gynaecology portfolio in India
Dawson joins Roche from the Peter MacCallum Cancer Centre, where he serves as Associate Director of Research
Backed by a multi-hundred-million-dollar investment, the expansion underscores Sanofi’s long-term commitment to India’s thriving life sciences ecosystem
Ind-Ra expects chronic therapies to outpace IPM as compliance improves and lifestyle diseases rise
Subscribe To Our Newsletter & Stay Updated